ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000286.1|Viguiepinol_1 # 150 # 1406 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.683	BGC0000286.1|Viguiepinol_1 	150	1406	+	Loose	890	25.409	smeF	42.55	3003057	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGTCCCGACGACGCCTATGTGCCCTGCGATCCCGCCCTGTTCCGGCAGATACTCAAGGACACCCGGCTCTACGACAAGGGCGGCCTGTTCTACGATCGGGGCCGCGAGGCCGTGGGAAACGGCCTGGTCACCAGTCGCTGGGCCGATCACCGTCGGCAACGCCCGCTGATGCAGCCGTCGTTCGACCACCGGCACATCGGCCACTACGCCGAACTGATGGCGGACGAGACGGAAGCCCTGATGCGCTCCTGGCGATCGGGCGAGGTCGTCGACGTCGACAAGGCGATGGCAAGACTCACTCTTCGCATCACGACCAGATCCCTTTTCTCGGTGCCCGCGGACCACACGTTGGTGGCCCAGGTGGAGAAATGGCTGCCGATTCTCATGGACGGCTTCTTCCGGCGCATGTTCGTGCCGGCGCGGGTTCTCTCGCTCGTTCCCGGGAAGATGAACCGGCAATACCCCCCCCCCATCGCGGAGATGCGCAAGCTCACCGAAGAGATCATCGACGAGGTGCGGCGCAAGAAGGACGAGGACCCCGGCCTGCTCGCGGGCCTGATGAACGCGCGCGACGAGACCACCGGGGCCCCGCTCGGAACGCAGGAGATCTTCGACCAGGTCCTGATCCTGCTGATCGCCGGGTCGGAGACCACCGCGACGGCGCTGGCGTTCACCTTCCATCTGCTCGGCGCGCACCCCGAGATCGGCGCCCGCCTGCGGGAGGAGGTCGACGGCGCGCTCGGCGGCCGGACGCCCCGCTTCGAGGATCTCTCCGGGCTGACGTTCACGAGGCAGGTGCTCATGGAGAGCCTTCGCCTCTATCCGCCGGCGTGGATGTTCACCCGGTCCACCACCACGGCCTGCGAACTCGGCGGGCACGCGTTCCCCGAGGGAACCACCTTCCTGCTCAGCCCCTACATCCTGCAGCACGACCCGGAGTTGTTCCCCCGGCCGGAGAGGTTCGATCCGGATCGCTGGCGGCCCGGCGCGATGAGCGACGTCGCACGCCGGTCGGTGCTGCCCTTCGGCGCGGGCGGCAGGAAGTGCATCGGCGACCAGTTCGCGCTCAACGAGGCGATGTTGGCCGTCGCGGCGATCGCCGGCCGCTGGAACCTGACCCCCGTCGGTGACCGGCCGATACGGCCCATCGCCCGCGCCACGCTCAAGACGGGCCCTCTTCCGATGAGGCTCCAGGAGCGCCCGCACGAACCGGTGCGGAATGCGACGACCACCGATCTCCGAGACCAGAGGTAG	MGPDDAYVPCDPALFRQILKDTRLYDKGGLFYDRGREAVGNGLVTSRWADHRRQRPLMQPSFDHRHIGHYAELMADETEALMRSWRSGEVVDVDKAMARLTLRITTRSLFSVPADHTLVAQVEKWLPILMDGFFRRMFVPARVLSLVPGKMNRQYPPPIAEMRKLTEEIIDEVRRKKDEDPGLLAGLMNARDETTGAPLGTQEIFDQVLILLIAGSETTATALAFTFHLLGAHPEIGARLREEVDGALGGRTPRFEDLSGLTFTRQVLMESLRLYPPAWMFTRSTTTACELGGHAFPEGTTFLLSPYILQHDPELFPRPERFDPDRWRPGAMSDVARRSVLPFGAGGRKCIGDQFALNEAMLAVAAIAGRWNLTPVGDRPIRPIARATLKTGPLPMRLQERPHEPVRNATTTDLRDQR	MEVIPMKSASLFLSIAATLALAGCSTLAPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWRDFFTDARLQQVIEQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDAGVTEQFSAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYGADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQDRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANANIGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIANADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGLDSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERG	89.70	gnl|BL_ORD_ID|592|hsp_num:0	634		
BGC0000286.1|Viguiepinol_3 # 2990 # 3877 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000286.1|Viguiepinol_3 	2990	3877	+	Loose	890	28.8758	cpxA	25.32	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTGCCCGTCACCGTGTGGCGCTGAAGGTCCTGGCCGATCTGCGGTCCTGGGCGGCGGAATACCCGCAGGTCCTCGAGGCCACGCCGATCGAAGCCCTGGCGATCTCCACCGCGGCGATCAGCCCGTGGCGCGGAGCGAACGAGCTCCGGCTGTCGGCCCCGGATGTACGCTGTGGGCCTACGCCCCTGGACGACCACGTCGAGCAGAACGTCCGGAGCCTCGACGAACTCGACGACCTGTTCGGTCGCTGCGAGGCCATCGTCCGGGGCGGCGACCGGGACGACGGCCATCCCCTGCTGGCCTCCCTGTCCGGCTGGCAGTCCGCTTTGGAGCGGGCTCCCCACTACCCGAAACTGGCCGGCCTGTGGGGCGACCGATTCGCCGAGGCCCTGCGCGGCGAGCGGTACGACTGGACCGCGGGTCTGGCCAGGGACCGCGGCGAGGGCCCTTCCGATCCGCAGGAGTACCTGACGTACGCCGCCAGCTCCAATGCGTGGATAACCCACTTCCCGCGCTGGGCGACCAGCGACCGGGACGATCTCCTCGATGGCCTGCCGGTCCTGGACAACGCCCTGGAGGCGATCGAAGTCGCCGTGCGCCTCTCCAACGACCTGGCCACCTTCGAGCGGGAGCGGGCCGAGCCCGGTCAGAACAACATCCTGATGTACGACACCTCACCCGACTGGGTGCACGACGAACTCGACCGGCATTCCCGCAAGGCGCAGGAGCAGCTCGACCCGCTGGCGACGGCCGGGTTCCCACCCGCTGTCGAGCTGCTCCGCCTGCTCGATTGGTCGGTCACCTTCTACAGCGGCGCCGACTTCCGGGGATGGGGATCCGACCGCGATCTCACCGGGCCGTCCGGCCTGCCCTCCGACATGTGA	MRARHRVALKVLADLRSWAAEYPQVLEATPIEALAISTAAISPWRGANELRLSAPDVRCGPTPLDDHVEQNVRSLDELDDLFGRCEAIVRGGDRDDGHPLLASLSGWQSALERAPHYPKLAGLWGDRFAEALRGERYDWTAGLARDRGEGPSDPQEYLTYAASSNAWITHFPRWATSDRDDLLDGLPVLDNALEAIEVAVRLSNDLATFERERAEPGQNNILMYDTSPDWVHDELDRHSRKAQEQLDPLATAGFPPAVELLRLLDWSVTFYSGADFRGWGSDRDLTGPSGLPSDM	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	64.55	gnl|BL_ORD_ID|136|hsp_num:0	152		
BGC0000286.1|Viguiepinol_4 # 4095 # 5177 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.680	BGC0000286.1|Viguiepinol_4 	4095	5177	+	Loose	800	26.9498	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	24.07	3003785	protein homolog model	n/a	n/a	fosfomycin	antibiotic target alteration	antibiotic-resistant murA transferase	ATGAGCCCCACCACCAGCCTTCACGAGCTGGGATCCGGCGTCCTGGACTCGGTTCATCTGCGCGGCCTGATCGACGAAAGACTGAACGCCTTCCTCGACGCCAAGTCCGGCAGGGACACGGATGTCCACCTGGTCTCGCTCATCGAGCACCTGCGTGACTTCCTGGCCGCGGGCGGCAAGCGCATACGGCCGCTCTTGTGCATGGTGGGCTGGCACGCGGCGGGAGGATACGGCGAAACGGAGCCCATCATCGGCGCGGCGGCCTCGCTCGAACTCTTCCACGCCTTCACCCTCATCCATGACGACGTGATGGACGCCTCCGACACCCGGCGCGGCCGTCCGACCCTTCACCGCACGCTGGAGACGGGTGCGAACGGCACGACCGCCGAGCGGTTCGGCACCAACAGCGCGATCCTGCTCGGCGACCTGGTCATGGTGTGGTCGGACGAGCTGCTGTACTCAAGCGGCCTCGACCAGCAGCAACTGGTCGCCGTTCGACCGCTGTTGGACGCCATGCGTACCGAGGTGATGATCGGTCAGTACCGGGATCTGCTGTCCACCGGGCAGCCCACCGCGGACGTCGAACGGTCGCTGGCAGTGATCCGCTACAAAACGGCCAAGTACACCGTGGAGCGGCCGCTGCACATCGGCGCGGCCCTTGCCGGAGCGGACCAGTCCCTGCTGGACGTCTGCACCGCCTACGCTCTTCCGATCGGAGAGGCCTTCCAACTGCGCGACGACCTGCTCGGCGTCTTCGGCGACCCGTCCAAGACCGGCAAGTCGACCCTGGACGACCTGCGGGAGGGCAAAGCGACAGCCCTGATGGCGCACGCCCTCCACACCGCCGGCACCGAGCAGGCGCGGGTGCTGAGGTCCCTGGTCGGCGACCCGGACCTGGACGAAGCAGGCGCCGAGACGGTCCGCGGGGTTCTACGGGCCACGGGCGCCGCCGACAAGGTGGAGCAGATGATCACCGATCGGGTGCAGCGTGCCCGGCGGGTCCTGGACGAGGCCCCGTTCCCGGACGAGGTCAAGAAGACCCTCGACACCTTCGTCACCACCACCACGCTCAGGACCACCTGA	MSPTTSLHELGSGVLDSVHLRGLIDERLNAFLDAKSGRDTDVHLVSLIEHLRDFLAAGGKRIRPLLCMVGWHAAGGYGETEPIIGAAASLELFHAFTLIHDDVMDASDTRRGRPTLHRTLETGANGTTAERFGTNSAILLGDLVMVWSDELLYSSGLDQQQLVAVRPLLDAMRTEVMIGQYRDLLSTGQPTADVERSLAVIRYKTAKYTVERPLHIGAALAGADQSLLDVCTAYALPIGEAFQLRDDLLGVFGDPSKTGKSTLDDLREGKATALMAHALHTAGTEQARVLRSLVGDPDLDEAGAETVRGVLRATGAADKVEQMITDRVQRARRVLDEAPFPDEVKKTLDTFVTTTTLRTT	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	81.08	gnl|BL_ORD_ID|2414|hsp_num:0	2291		
BGC0000286.1|Viguiepinol_5 # 5355 # 6386 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.708	BGC0000286.1|Viguiepinol_5 	5355	6386	+	Loose	1050	27.7202	vgaALC	30.86	3002830	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGAAATTTCGACAAGGGGAGCTGAATACGTCGACTCCACCGGCCTCGGTGGCGGGGACAGCGGAAAGCCGCCGCGCCCGCTCGGTCGGCACCGGCCGCGCCCACGCCAAGTCCATTTTGCTGGGGGAGCACGCGGTCGTCTACGGAGCCCCGGCGCTCGCCCTGCCCGTTCCGCAGCTGTCGATCACCGCCAGCGCCGGGTTCTCCAACCGCGGTGGGGAAGCGGCCGGCGTGTCCTTCACGATGACCGGATCCGCCTGGAAGCAGGTCGGAACGCAGGCATCCGAGGGGCTGCGCCGGCTGACCACCGACTTCAGGGCGTCCATGGGCATCGACGAGGGACCGCACCTCGATGTGATCATCGACGGTTCCATCCCGCTCGGCAGGGGACTTGGCTCCAGCGCGGCCTGCGCCCGTGCCGTCGTCCTCGCCCTGGCCGACCTCTGCGGCCGCGAGGTCTCGCAGCGGACGACGTTCGACCTGGTGCAGACCGCCGAGAACGTGATGCACGGCAAGGCCAGCGGCGTCGACGCCGTCACCGTGGGCGCGAGCGCCCCGTTGCTGTTCCAGGCGGGCGAGGCCCGCACGCTGCGTGTCGGCTGCGACGCGCTGTTCGTCATCGCGGACAGCGGCGCCGTCGGCAGCACCAAAGAAGCGGTCGACAAACTGCGGGAGAGGTTCCGGCTCCACGCCGGAACACAGGAGAGGTTCGTACGCCGGGCGTCGGAACTGACTGGCGAACCGGTGGCCGCCCTCGCCGCCGGCCAGCCGGAGGAGCTCGGCTCCCTGCTGACGGAGTACCACGGACTGCTCCGCGAGGCCGGGCTGAGCACCGACCGGATCGAGGCGATGGTGAGTGCCGCGCTCGCCGCAGACAGCCTCGGCGCCAAGATCACCGGCGGCGGACTGGGCGGCTGCGTCCTTGCGCTGACCCAGCCCGAGCAGGCGAGAGAGGTCACCCGGCGGCTGCACGAAGCGGGGGCCGTGCAGACGTGGATCGTCCCGCTGAGGAGGCTCGTCACTCATGTCTGA	MKFRQGELNTSTPPASVAGTAESRRARSVGTGRAHAKSILLGEHAVVYGAPALALPVPQLSITASAGFSNRGGEAAGVSFTMTGSAWKQVGTQASEGLRRLTTDFRASMGIDEGPHLDVIIDGSIPLGRGLGSSAACARAVVLALADLCGREVSQRTTFDLVQTAENVMHGKASGVDAVTVGASAPLLFQAGEARTLRVGCDALFVIADSGAVGSTKEAVDKLRERFRLHAGTQERFVRRASELTGEPVAALAAGQPEELGSLLTEYHGLLREAGLSTDRIEAMVSAALAADSLGAKITGGGLGGCVLALTQPEQAREVTRRLHEAGAVQTWIVPLRRLVTHV	MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK	65.71	gnl|BL_ORD_ID|143|hsp_num:0	159		
BGC0000286.1|Viguiepinol_6 # 6379 # 7431 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.725	BGC0000286.1|Viguiepinol_6 	6379	7431	+	Loose	1950	30.8018	MexB	25.0	3000378	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTGAGCAACAGATCGCCGTCCTCCGCCCGCGGGAACAGCCGGGTGCGAACGGGGTCACCGCCGTCGCGCAGCCGAACATCGCGCTGATCAAGTACTGGGGGAAGCGGGACGAGCACCTCTTCCTCCCGTGGACCAGCAGCCTGTCGATGACCCTGGACATCTTCCCCACGACCACCCGTGTCCACCTCGACGCCGAGGCCACGGACGACGAAGTGACCTTCAACGGCGCACCCGCGGCGGGCGAAGAACGGCGGCGCATCACCGGATTCCTCGATCTGGTGCGCCAACGGGCCGGGCTCACGCACCGGGCCGTCGTCGACACCCGCAACACCGTGCCCACCGGGGCGGGCCTCGCGTCCTCCGCCGGCGGGTTCGCCGCACTCGCCGTCGCCGCCGCCACCGCGTACGGACTGGACCTCGACGACACCGGTCTCTCCCGCCTGGCCCGCCGCGGCTCCGGCTCGGCCTCGCGGTCGATCTTCGGCGGCTTCGCCGTCTGGAACGCCGGCACTCCCACGGCGCCCCCTGCGGAGGCCGACCTCAGCTCCTACGCGGAGCCGGTACCTGTGGGCGACCTCGACCCCGCACTGGTCATCGCGGTGGTGAACGCCGGTCCCAAGGACGTGTCCAGCCGCGCGGCCATGCGCCGAACCGTCGAGACCTCACCCCTGTTCGAGCCCTGGGCCGCGTCGAGCCGGGACGACCTGACCGAGATGAGACAGGCGCTCCTGCGCGCCGACCTCGACGCGGTGGGCGAGATCGCCGAGCGCAACTCGCTCGGCATGCACGCGACCATGCTGAGCGCGCGCCCTGCGGTGCGCTACCTCTCGCCCGCCTCGCTCACCGTCCTCGACAGCGTGCTGCGGCTTCGGCGCGACGGCATATCGGCCTACGCGACCATGGACGCCGGACCGAATGTCAAGGTGCTCTGCCGTCGTGCGGACGCCGACCTGGTCGCCGAGGCCGTGCGCGCCGCCGCCGCGGGCGGCACCGTGCACATCGCCGGGACGGGGCAGGGCGCCCGCCTGATCGACGAGGACGGACGATGA	MSEQQIAVLRPREQPGANGVTAVAQPNIALIKYWGKRDEHLFLPWTSSLSMTLDIFPTTTRVHLDAEATDDEVTFNGAPAAGEERRRITGFLDLVRQRAGLTHRAVVDTRNTVPTGAGLASSAGGFAALAVAAATAYGLDLDDTGLSRLARRGSGSASRSIFGGFAVWNAGTPTAPPAEADLSSYAEPVPVGDLDPALVIAVVNAGPKDVSSRAAMRRTVETSPLFEPWAASSRDDLTEMRQALLRADLDAVGEIAERNSLGMHATMLSARPAVRYLSPASLTVLDSVLRLRRDGISAYATMDAGPNVKVLCRRADADLVAEAVRAAAAGGTVHIAGTGQGARLIDEDGR	MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ	33.46	gnl|BL_ORD_ID|1832|hsp_num:0	1925		
BGC0000286.1|Viguiepinol_7 # 7428 # 8555 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.733	BGC0000286.1|Viguiepinol_7 	7428	8555	+	Loose	510	28.1054	OXA-283	37.04	3001738	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCTCCGGGCGAACGGTCGTCCGCAGCGCGCCCGGCAAGCTGTTCGTCGCGGGCGAGTACGCGGTGGTGGAGCCCGGTACCCCGGCCGTCCTGGTGGCCGTGGACCGGGAGATCACCGTCATGGCGACCCTCTCCGACGCGGCCGACATCGTGATCTCCTCCGATCTCGTCCCCCGAGCGGTGACGTGGCGATGGCGCGACGGGCGGCTCCACGCGCCCGGCACGAAGAACGGGGACGCCGACGGGGACGGCGCACGCGGCGCACTGGCGCACGTGGTGTCAGCGGTCGAGACCGTGCGGAGACTCCTGGTCGAACGCGGCCTGCCCCTGCCCGGGCTGGAGATCTCGATCAGCAGCCGGCTGCACGACAACGGCCGCAAGTACGGCCTGGGGTCGAGCGGTGCGGTGACCGTGGCCACGATCGACGCCCTCACGTCCCTGTGCGGACTGGACCTCTCGCTCGACGCCCGGTACCGCCTGGCCGTGATCTCCTCGGCCGGGATCGACCCCAAGGGCTCCGGCGGTGACCTCGCCGCCAGTACATGGGGCGGCTGGATCGCGTACCAGGCACCCGACCGGGCCTTCGTGCTCGACCTCACCCGCCGCCACGGCATCGAGGAAGCGCTCCGCACCCCCTGGCCGGGCCTCGCGGTCCGAAGGCTTCCGGCCCCCCGCGGCCTCACCCTCGAAGTCGGCTGGACCGGCAGCCCGGCCTCGACCACCTCGCTCGTGTCCGGTCTGCACCGCCGGACCTGGCGCGGCACCGCCTCGCACCGCGCGTTCCTGGAGACCTCCACCGACTTCGTACGCGCCTCGATCACCGCCCTCGAGGCCGGCGACGACCAGAGCCTGCTGCGCCAGATCCGCCGTGCCCGGCAGGAGCTGGCCTGCCTCGACGACGAAGTCGGGCTCGGCATCTTCACACCCGAGCTGACGGCCCTGTGCGCGGTCGCCGAAACCGTCGGCGGCGCCGCCAAGCCGTCGGGCGCGGGCGGCGGCGACTGCGGCATCGCTCTGCTCGACGCCGAAGCCACGCACGACATCTCGCACGTACGGCAAGGGTGGGCCGCGGCCGGTGTGCTGGCCCTGCCCGTCCGGCCCGCCCCGAAAGGGATCGAGGAATGA	MTSGRTVVRSAPGKLFVAGEYAVVEPGTPAVLVAVDREITVMATLSDAADIVISSDLVPRAVTWRWRDGRLHAPGTKNGDADGDGARGALAHVVSAVETVRRLLVERGLPLPGLEISISSRLHDNGRKYGLGSSGAVTVATIDALTSLCGLDLSLDARYRLAVISSAGIDPKGSGGDLAASTWGGWIAYQAPDRAFVLDLTRRHGIEEALRTPWPGLAVRRLPAPRGLTLEVGWTGSPASTTSLVSGLHRRTWRGTASHRAFLETSTDFVRASITALEAGDDQSLLRQIRRARQELACLDDEVGLGIFTPELTALCAVAETVGGAAKPSGAGGGDCGIALLDAEATHDISHVRQGWAAAGVLALPVRPAPKGIEE	MKILILLPLLSCLGLTACSLPVSSLLSQSTSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG	135.87	gnl|BL_ORD_ID|2718|hsp_num:0	3448		
BGC0000286.1|Viguiepinol_8 # 8552 # 9643 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.712	BGC0000286.1|Viguiepinol_8 	8552	9643	+	Loose	700	28.4906	oleD	29.2	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGCGTTCAGCGCAAGGACGACCACGTCCGGCTCGCCATCGAGCAGCAGGACACCCGCAGCGGGATCAATCAGTTCGACGAGGTGTCCTTCGTACACCACGCCCTGGCCGGCATCGACCGGCCGCAGGTGTCCCTGGGCACGAGCTTCGCCGGGATCTCCTGGCAGGTGCCGCTCTACATCAACGCGATGACCGGCGGCACCGCCAGGACCGGCGTCATCAACCGGGGCCTGGCGACGGCCGCCCGCGAGACCGGGGTACCCCTCGCGTCGGGCTCCGTGCACGCCTACCTCAAGGACCCGACGTGCGCCGACACCTTCCGCGTCCTGCGCCGGGAGAACCCCCACGGGTTCGTCATGGCCAACGTGAACGCGACGGCATCGGTCGCCGACACCCGGCGTGCCATCGATCTGCTGGAGGCCGACGCCCTGCAGATCCACGTCAATACGGCGCAGGAGACGGCGATGCCGGAGGGCGACCGGTCCTTCGGATCCTGGGTCTCGCAGATCGAGAAGATCACGGCGGCCGTCGACCTGCCCGTGATCGTCAAGGAGGTCGGCAACGGCCTGAGCCGCGAGACCGTCCTGACGCTGCGACAGCTGGGTGTCAGCGTGGCGGACCTCGGCGGCCGGGGCGGCACCGACTTCGCCCGCATCGAGAACGGCCGGCGCCCGCTCGGCGACTACGCCTTCCTCCACGACTGGGGCCAGTCCACCGCCGCCTGCCTCCTGGACGCGCAGGGCGCCGGTCTCCCCGTGCTCGCCTCCGGCGGCGTCCGCCATCCCCTCGACGCCGCCCGAGCCCTGGCCTTGGGCGCCTCCGGCGTCGGGGCCTCCGGAGTGTTCCCGCGCACCCTGCTCGACGGCGGTGTCGAGGCGCTGATCGCACAGATCACGAACTGGCTGGACCAGCTCGCGGCCCTGCAGACCATGCTCGGCGCACGCACCCCCGCCGAGCTCGCGAGCAAGGACCTGCTGATCCACGGCACCCTGCGAACCTTCTGCGCCGACCGGGACATCGACGCGGGGCGACTCGCCCGGCGTACCCGATCGGCCGACGCCCTCCACGATTCGACGGGAAGAGCACGATGA	MSVQRKDDHVRLAIEQQDTRSGINQFDEVSFVHHALAGIDRPQVSLGTSFAGISWQVPLYINAMTGGTARTGVINRGLATAARETGVPLASGSVHAYLKDPTCADTFRVLRRENPHGFVMANVNATASVADTRRAIDLLEADALQIHVNTAQETAMPEGDRSFGSWVSQIEKITAAVDLPVIVKEVGNGLSRETVLTLRQLGVSVADLGGRGGTDFARIENGRRPLGDYAFLHDWGQSTAACLLDAQGAGLPVLASGGVRHPLDAARALALGASGVGASGVFPRTLLDGGVEALIAQITNWLDQLAALQTMLGARTPAELASKDLLIHGTLRTFCADRDIDAGRLARRTRSADALHDSTGRAR	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	87.47	gnl|BL_ORD_ID|1284|hsp_num:0	1367		
BGC0000286.1|Viguiepinol_11 # 11991 # 12971 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.698	BGC0000286.1|Viguiepinol_11 	11991	12971	+	Loose	850	28.8758	abeM	28.3	3000753	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; acridine dye; triclosan	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGACCGACCTCAGGATTCTCGGTACGGGTGCCTATGTGCCGGAGCGAATCGCGTCCAATGACGAGGTCGCCGCGGCGGCGGGGGTCGACGACGCGTGGATCACCGCCAAGACCGGCATCCGGGAACGGCGATGGGCTGCCGACGACCAGGCCACCTCGGACCTGGCCACCGCCGCGGGGCGGGCCGCGCTGCGGTCGGCCGGCATCACCGCCGAGGACCTGTCCGTGATCGTGGTCGCCACGTCCACACCCGACCGGCCCCAACCGCCCACCGCCGCCTACGTCCAGCAGCGGCTCGGCGCGAGCGACGCGGCCGCGTTCGACGTCAACGCGGTCTGCTCCGGCATGGTGTTCGCGCTCGCCGCGGCCGAGGGCGTACTCACCCGCACCGGCGGCCACGCACTGGTCATCGGCGCGGACCTGTATTCCCGCATCCTGAACCGGGCCGACCGCAGGACCGTGATCCTTTTCGGGGACGGTGCCGGAGCGGTGATCCTGGGGTCGTCGGTCGACCACGGACCACGTATCCGGCACCTCGCGCTGCACTCGTTCGGCGAACTGTCGGGGCTCATCGAGGTGCCCGCCGGCGGCAGTCGCATGCCCGTGGACCAGACAGTCCTCGACGCAGGGCTTCAGTACTTCGCGATGGACGGGCGAGGCGTGCGGAACTTCGTCTGTGACCACCTGCCGCAGCTGGTCAAGGGATTCCTGCACAAATGCGGTGTCGTACCCGACGACATCGACCACTTCGTACCGCACCAGGCCAACGGCACCATGCTGGACAGCCTCTTCGCCGATTTGGAACTGCCTCGCGCGACCATGCACCGCACACTGACGCACTACGCCAACACGGGAGCCGCCTCCATCCCGATCACCCTGGACGCGGCCGCCCGCGCCGGCGCCTTCAACCCCGGCGACCTGATCCTCATGGCCGGCTTCGGCGGCGGCATGTCGGCGGGATTCGCGCTGGTCGAGTGGTGA	MTDLRILGTGAYVPERIASNDEVAAAAGVDDAWITAKTGIRERRWAADDQATSDLATAAGRAALRSAGITAEDLSVIVVATSTPDRPQPPTAAYVQQRLGASDAAAFDVNAVCSGMVFALAAAEGVLTRTGGHALVIGADLYSRILNRADRRTVILFGDGAGAVILGSSVDHGPRIRHLALHSFGELSGLIEVPAGGSRMPVDQTVLDAGLQYFAMDGRGVRNFVCDHLPQLVKGFLHKCGVVPDDIDHFVPHQANGTMLDSLFADLELPRATMHRTLTHYANTGAASIPITLDAAARAGAFNPGDLILMAGFGGGMSAGFALVEW	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	72.77	gnl|BL_ORD_ID|1285|hsp_num:0	1368		
BGC0000286.1|Viguiepinol_12 # 13133 # 13246 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.658	BGC0000286.1|Viguiepinol_12 	13133	13246	+	Loose	330	21.557	AAC(6')-Ian	64.29	3003200	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGCGGAGAAGTTCGGCGGCGACTCGGTGCCCGAGACCCGGCGCAACGTCCAGTCGTACCTCGGCCAGGTGCCCCGGTACCCAATCGATTCCGAAGGCAAGGGGAACAAGTGA	MAEKFGGDSVPETRRNVQSYLGQVPRYPIDSEGKGNK	MLVQQGRLAIRALQKSDAPVMLRWLQDERVLEFYEGRDKHFDLQTVIEVFIEDQGETTPCLVLLDDKPLGYVQFYPLDSEDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTELVSLVRDYLITDKAAQRLVLDPQSRNSRAIACYEKCGFEKLRLLPAHEMHEGQLQDCWLMQYYPARSSLMASSRPKI	19.47	gnl|BL_ORD_ID|2162|hsp_num:0	3319		
BGC0000286.1|Viguiepinol_13 # 13243 # 13872 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.678	BGC0000286.1|Viguiepinol_13 	13243	13872	+	Loose	650	25.409	vanB	30.77	3000013	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGACAGACCGTCCGTTCTACGTGCTGCTGGGGCCGGACTACGCCGGGAAGTCCTCCGTGATGACGGAGCTCTCGGCGGCGATGCCCGGCTGGCAGACCCTGTCGACCGACGACGACCTCGTGGCCGGGGAGCACCGTCTGATCTCGCAGCTGCGCCGGAACGTCGTCCGGGACGTGCTGCCGGGCCTGGGGCCCACGTACTCCGCCGACTTCCTCGCGAGTCTGCTGGGCACGGCCGTCGTGCACCTGAGGGATCAGCTCGAACGGCAGGAGCCGGACGTGCCGGTCTTGATGGACTCGTACTACTACAAGATCCTCGCGAAGTGTCGACTCGCCGGGCTTGAAATGCACCCCCTGTACACCTGGTGGCGTTCCTTTCCCCTGCCGCGCGGAGTGATCTATCTGGACGTCTCGCCCGAGACCGCCTGGCGTCGCTCGGGACGCGGAGCGCAGCTCAACCCCCTCGAGCACTTCGGCGACCGGCCCGAGTGGTTCGGCTTCGAGAGCTATCAGAAGAACCTCGGCAAGCTGTTGCTGGAGGAAACGGGACAACTGCCCGTCACGGTGGTCGAGGAGCGGTCCGGGACGGCTGCGACCGCCGCGGCCGTGCGGGAGGTCCTGGCGGCATGA	MTDRPFYVLLGPDYAGKSSVMTELSAAMPGWQTLSTDDDLVAGEHRLISQLRRNVVRDVLPGLGPTYSADFLASLLGTAVVHLRDQLERQEPDVPVLMDSYYYKILAKCRLAGLEMHPLYTWWRSFPLPRGVIYLDVSPETAWRRSGRGAQLNPLEHFGDRPEWFGFESYQKNLGKLLLEETGQLPVTVVEERSGTAATAAAVREVLAA	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	61.11	gnl|BL_ORD_ID|1031|hsp_num:0	1098		
BGC0000286.1|Viguiepinol_14 # 13869 # 15569 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000286.1|Viguiepinol_14 	13869	15569	+	Loose	1000	27.335	MCR-8.1	42.86	3004516	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAGCGAGACCCAGGGCTGGGGCACACCCGGCCACGCCGACCGCTACCGGGAGCGGGTGTTCGCCGAGCGGGCGCAGCTGAGCGCGGGCCTCGACGACCTGCCGCAACAGCAACAACGTGTGCTGGACGATCTGTTGGAGTTCAACGGCGGTACCGAGTTCGGACGCCGCCACGGCTTCGCCGCAATCCGTACTCTGAAGGACTACCGGGCGGCCGTGCCCATCCAGGACTACGCGGCGCACGCCCCGCTGATCGAACGCATGGCGGCGGGCGAGCCGAACCTGCTGACCCAGGACGCGCCGGTGGTGTACTTCACCAGCAGCGGAAGCACCGGGGACCACAAGAAGATCCCGATCACCCGCCGCTTCATGAAGACCGTCTTCTTCCCCTTCTACTACGCGGCCTGGGCGCCGTTGATCGAAAGTCTCCCGGAGCTCATGGAGCGCCCGGACGCGGTGCTGAACCTCAAGCACGATCCGCTCGCCGTTCCTCCCGTCACGACCAGCGGGCGTCCCCATGTGGGGGCCAGCCAGGTCGACTTCGGCGCGGCGTTCGGCGAACCGCTCTCGGCCGAACTGGGCACCGCCGCGCCCTGGGCCACCCTTCCCGTGGACGTCGCGCCCGACGACCACCTGGAGAAGATGTACCTGCGGTTGCGACTGGCGGTGCAGAGCGACGTGCGGGGCCTCATCGGGATCAACCCGGCGATGATCGCGGCCGTGCCCTATCAGCTCGAGCTGTGGTGGCAGCGCATCGTCAAGGAGGTCCGCGACGGGACCCTGGGCGGAGTGCCGTACGGGGACCCCGATCCGGAGCGCGCCGCCCGGCTGGAGTTCCTCGCCGGCCACTTCGGACGGCCCAGCCCGGCTCACGTCTGGCCGCAGGTTCGAGCGTTGTTTGGCTGGTCGACCGGCGTGGCCTCCCTGTACATGCCGGGCCTGCGTGAGCGGTTCGGGGCTGGAGTCAGGGTCCTGCCCGCGCCGGTGGCCGCGTCGGAGGGGCCGGTGGCGGTGCCGCTCGACCGGCACCCCGCCGCGGGCAGCCTCGTCCCCTCCGCCGCCGTGTACGAGTTCGTGGACGCCGACGAGGACCTCGGCCCCGGCGCCGAGACGCTCGTGGCGGAGGAACTCGAACCGAACCGGGACTACCACGTGCTCTTCAGCCACGTCGGAGGCCTCTACCGGTACGCCGTCGGGGACGTGGTCCGCGTGGTGGACCGTGTCCGGGGGGTGCCGCGGGTCCTGTACGCGGGCCGTGCCACCCGGTCGGATGCGGCCGGGGAGCGGCTGCGCGAGGCCCAGGTGGTGCGGGCGTTGGGAGAAGCACTGGCGAGCACTGGCCTCGCGCTGCGCAACGTGGCGTGCCGGGTGGAGGAAACGGCGGGCGAGGCGCCCCGGTATGTGTTCGCGGTGGCCCCGGAGGCTCCGTGGCTGGAGTCCGAGACCGTGCGGTTCGCCAGACTGCTCGATGCGGCGCTCGCCGCCGAGTCCCCGGGATACGCCAGGGCTCTGCGGGAGCGGCGGCTCGGTGCCGCGACGCTGCGGCTGCTGCACATCGACGCCTTCCAGCGCGAGTGGCACGCCCGCGTGGCGGACGGCGTCCGGCCCACCCAGGTCAAGGACCGGCTGTTCCGGCAGGACGAGAGCCAGTGGCGGCGACTGATCGCCGCGTCCGACGCACTACGAGGAGAAGGCACATGA	MSETQGWGTPGHADRYRERVFAERAQLSAGLDDLPQQQQRVLDDLLEFNGGTEFGRRHGFAAIRTLKDYRAAVPIQDYAAHAPLIERMAAGEPNLLTQDAPVVYFTSSGSTGDHKKIPITRRFMKTVFFPFYYAAWAPLIESLPELMERPDAVLNLKHDPLAVPPVTTSGRPHVGASQVDFGAAFGEPLSAELGTAAPWATLPVDVAPDDHLEKMYLRLRLAVQSDVRGLIGINPAMIAAVPYQLELWWQRIVKEVRDGTLGGVPYGDPDPERAARLEFLAGHFGRPSPAHVWPQVRALFGWSTGVASLYMPGLRERFGAGVRVLPAPVAASEGPVAVPLDRHPAAGSLVPSAAVYEFVDADEDLGPGAETLVAEELEPNRDYHVLFSHVGGLYRYAVGDVVRVVDRVRGVPRVLYAGRATRSDAAGERLREAQVVRALGEALASTGLALRNVACRVEETAGEAPRYVFAVAPEAPWLESETVRFARLLDAALAAESPGYARALRERRLGAATLRLLHIDAFQREWHARVADGVRPTQVKDRLFRQDESQWRRLIAASDALRGEGT	MFKYLLSFKLNPVQRTWAAAFFFTTIGNIALWQTLWINVDVHNIHNLLFFASLPIFLFCFLSILLTPVMVIPYLCRPLLVVLILISACCSYFMMKYNILIDRSMVQNFFETNQAELTSYLSVPFLSTLFLLGIVPAIILALPSTDNKRGAFRIELWWLAHICIAVVLLAMVTMVFYKDYASLIRNNMQIKDQALPFNFVRNTNGYLKRKYQASSTILQSVGEDAVRPIYSNAPPKLVVVVVGETARAQNFQLNGYSRVTNPYLSRRHDVISFKNVSSCGTATAISLPCMFSRMSRNEYNEVRAASEENLLDILKRTGVEVLWRNNNNGGCKGICKRVPTDDMPAMKVIGECVNKDGTCFDEVLLNQLSSRINAMQGDALIVLHQMGSHGPTYFERYPSTSKVFSPTCDSNLIEKCSNKELVNTYDNTLVYTDRMLSKTIELLQRYSGMRDVAMIYLSDHGESLGESGIYLHGTPYIIAPNEQTHIPMFMWFSSSFAQHSKLNLECLTGNADKQYSHDNFYHSILGLFNVKTSVYKPELDMFTLCRQSDHTPLSSAVVREKTDGNG	100.18	gnl|BL_ORD_ID|2740|hsp_num:0	3144		
BGC0000286.1|Viguiepinol_15 # 15566 # 16432 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000286.1|Viguiepinol_15 	15566	16432	+	Loose	2000	27.335	oqxB	32.35	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATGCATGTCCAGGATCCCGTCGACCCCGTGGAGACGACTGCCCTGCTGACCGCCGCCCTGCGCGCCGCCGAGAGCGGGCGGGAGGACCGGCTCTACAAGGATCCGTACGCGGCCGCGCTGGTGGGGGACGCAGGCCCCCGGCTCCTGGCGGAGATCCGTGCCGCGACCTTCCCGCCGGACGGGCCGCGGAGCGTGCCCAGTACCCCCGACTACAACGCGATCCGCACCAGATTCTTCGATGACCTCCTCCAAGAGGCCGTACAGGACCAGGGGATGACCCAGCTCGTCGTGGCCCCGGCCGGCATGGACTCCCGTGCCTACCGGCTGCCCTGGCCGCGACACCTGCGGTACTTCGAGGTCGACCGGCCGTCGGTGCTCGCGTTCAAGGAGGAGCGCCTGCGCGGGGTCGACCCGCGCGTCGACCACGTCACCGTCGCCGTCGACCTGACCGCGGACGACTGGGAGGACCGGCTCCGCGCCTCCGGATACGACCCGAGCACGCCGTCCACCTGGCTGCTCGAAGGGCTGCTGTACTACATCCCTGAGAAGGACACCGAGCGCATGCTGGAGCGGGTCGGCGCATTCTGTGCTCCGGGCAGCCGCATCGCCGCCGACCTCGTCAACTCCGCGGCCCTCACCCTCCCGCACATGCGTCCCCTCCTGGACGTCTTCAGCGGCTGGGGCTGCCCCTGGCTCTTCGGCAGCGACGAGCCCGAGGCGCTCTTCGAGCGGTACGGCTTCGACGTGGCCGCGGTCCAGCCCGGTGAGCCCGGGGCCCACTTCGGACGCTGGCCGGACCCGGTCCCCGACCGCGCCGTCAAGGACGTGCGGCGGGTGTTCTTCGTGCACGGCCAACGCCGGTGA	MMHVQDPVDPVETTALLTAALRAAESGREDRLYKDPYAAALVGDAGPRLLAEIRAATFPPDGPRSVPSTPDYNAIRTRFFDDLLQEAVQDQGMTQLVVAPAGMDSRAYRLPWPRHLRYFEVDRPSVLAFKEERLRGVDPRVDHVTVAVDLTADDWEDRLRASGYDPSTPSTWLLEGLLYYIPEKDTERMLERVGAFCAPGSRIAADLVNSAALTLPHMRPLLDVFSGWGCPWLFGSDEPEALFERYGFDVAAVQPGEPGAHFGRWPDPVPDRAVKDVRRVFFVHGQRR	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	27.43	gnl|BL_ORD_ID|2212|hsp_num:0	2400		
BGC0000286.1|Viguiepinol_16 # 16429 # 17862 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	BGC0000286.1|Viguiepinol_16 	16429	17862	+	Loose	760	32.7278	Tet(X3)	23.29	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGACCGGGCCCGTCGTGGTGGGCGGCAGCGTCGCGGGGCTCGCCGCCGGCCTCGCCCTGGCGTTACGGGGCCTGCCCGTCCGGGTGCTGGAGCAGGCGCCCGTACCGCCGGAAGGGCCGCCGGGGAAGGCGGCCGAGCTGTGGAAGAGGCCCACTGTCGCGCAGAACGGCCACTCCCACGTCCTGACCTCGCTCGGCGTACGGGTGCTGCGGGCCCACGTCCCTCAGGTGCTCGACGCCGCTTTGGAGGCCGGCGCACGCATGCTCGACCTCATGCGGGCGCTGCCGGTACGGGCCGACGATGGGATCCGCCGCCAGGGCGACGAGGAACTCGTGGCCCTCGCCGTGCGCCGCCCGGTCTTCGAACTCGTCCTCCGCCAGGCGCTGCGGTCGCTGCCGAACGTCACGATCAGCCATGACGTCAAGGTCATAGGCCTGCGCACGACGCCCTCGGGGAACCGGGTGACGGGCCTGGTGACCGGCGACGGCGAGGACATCCCCACGCATACGGTCGTGGACGCCACCGGACGCCGGTCGGCGTCGCGGTCCTGGCTCACCGCCGCCGGATTTCCCCCGGAAGCCGCGAGGACCGCCCCCACCCGGGTGCGCGCCTTCACCCGCTTCTACCGGCTCAGGTCCCCCGGCACGCTGCCCGGACCGCTCAACCGCGGCAACGCGGCGGGCGGCATCTGGGACCACTACGCGGCGGTCGCACACCTCGCCGACAACGACACGTACGCCCTGACCGTCGGCGTGCCCACTGCGGATCCGGCGACGACAGGCCTGCGGCATCCGGCCGCCTTCACCGCGGTCGCCCGTCTTTCGCCGTACCTCGCCGCCTGGGCCGATCCCGCGGTGGGGGAGCCGATCAGCGCGGTGCGAGCCATCACCCTGCCGCCCAACACGCTGCACTGCGCACCCGACGCCGGCGCCGGGCCGATCGCGGGCCTGTACCCGGTCGGGGACGCCGCGTGTGTCACCGACCCGCTCTTCGGGCGGGGCATGTCGCTGGCCCTGCGGCACGCTTTCCTGCTCGCGGATTTCCTGGCGGACGAGCCGGCGGTCGAGGAGCAGGGTGAACGTGCCGCACGCATCGCCGACGGCGTCTACCGGTCGTGGTACGAGCAGTCCGTCCGCGAGGACGCGGCACGCACGGCCCTGTGGCAGGCGAGGGTCACGGGATGCCCGCCGCCGACGGTATCGGAGTCCGGCCGCGCAGCACTGTCCGAAGTCGCCCGGGCGGCGGCCGCCGACGGGACCGTGTGGCGCGGCCTCACCCGCGTGCTGATGGGCCTGGAGACCGTCGAGGACGTCTTCGACGACGAGGCGTTCCGCCGACGGGTACGGACGGCCCCCGAACCGGCCGCGGCCGCGCCGCGCCCACTGACGCGGGAGGAACTGGTCGCCGCCGTCAGAGACGAGGTGCGCGCATGA	MTGPVVVGGSVAGLAAGLALALRGLPVRVLEQAPVPPEGPPGKAAELWKRPTVAQNGHSHVLTSLGVRVLRAHVPQVLDAALEAGARMLDLMRALPVRADDGIRRQGDEELVALAVRRPVFELVLRQALRSLPNVTISHDVKVIGLRTTPSGNRVTGLVTGDGEDIPTHTVVDATGRRSASRSWLTAAGFPPEAARTAPTRVRAFTRFYRLRSPGTLPGPLNRGNAAGGIWDHYAAVAHLADNDTYALTVGVPTADPATTGLRHPAAFTAVARLSPYLAAWADPAVGEPISAVRAITLPPNTLHCAPDAGAGPIAGLYPVGDAACVTDPLFGRGMSLALRHAFLLADFLADEPAVEEQGERAARIADGVYRSWYEQSVREDAARTALWQARVTGCPPPTVSESGRAALSEVARAAAADGTVWRGLTRVLMGLETVEDVFDDEAFRRRVRTAPEPAAAAPRPLTREELVAAVRDEVRA	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	122.94	gnl|BL_ORD_ID|2309|hsp_num:0	3401		
BGC0000286.1|Viguiepinol_17 # 17859 # 18998 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000286.1|Viguiepinol_17 	17859	18998	+	Loose	375	27.335	Escherichia coli acrR with mutation conferring multidrug antibiotic resistance	35.29	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGCGTCGGACCGTTCCCAGACGCGCCGTCGAAAGGTGCTGCTCGCACCCGTCACGGTTACCCCGGCCAAACCGCTCACACCCAGCCACCTCAAAGGTCTGCTGTGGACCGACGTCATGTTCCGGGCCACCGCGCCGCTCGCGGACGTGACCTACCGCTACAGCCCCACGACCTACCACCTCACCGAACAGACCCTAGGATTCTGGGAGTTCCTCGACCGCACGCAGAAGGGCCTGCCCTACGCCTCACTTTCCGAGGAGGAGATCGGCGAGCTGTACGTCCGGTTCCGGGCCTGCGCGCCCCCACCGGCCGACGCCTTGCGCCCCTACGCACACCAGGTCGAGAGCAACGGCTGGGTGCACCCGGCCAGTGAACGCGTTCTGCGCCTGTGGCGCGAGCACTACGCTCAACTCGGACTCCACGACCCTGGCCTGACGGTCCATCAACCGCCAGGGCTCGGCACGGAGGAGATGATCGAACGGCTCGTCGCCCTCGGCCTGGGGCTCGACCATCGCTCCAGCGGCGGTCCCGTGTACCTCGACGCCACTCGGCACGGTCTGCCCCTGCGCCAGATCGTGACGGCGGACGGCCGCCCGAACTACCTTGCCTGCGCCCTGCGGGAACTGCTTCCGCTGGCACCCGCGTATGACGAGGTCGTGCTCCTGTACGACACCGATCTCGACGCGGACTACCGGCTGCTGCAGCGCGCGCTGACCCAGCTGGGGCCGCTGGTGCACCGCGTCCCGATCGGTCGCGTGCCCATCGACGGCACGATCAGATCGGCGCGGCACGGCGGCTGGCACGCTTACACGGCGGGCGCCCTGCTCAAGGCCGTCGGCACGGAGGCCGACGCGGACGTACGCCGTCTCGGCGTACGGCTGTACTTCGTCGCCGTCCTCGGTCCCGGACAGGCGCAGTCCTTCCGCACCGACCTGCTTCACAGGAGCCTGGACCGGGCGCGGCAGCTGCTGCGCCGGACGACCGAGCGCGGGCCCGGCACTTCGCCTCTCGTGGACGACCTGCGCCGGCACCGGCGCGACCACACCCATGTCGATCCCTATCGGCTCACCTCGTCCCTGCTGGCCCGGGCCCGCCGCACCATCGACCGCGACCTGCTCTCCACGGTGTACCTATGA	MTASDRSQTRRRKVLLAPVTVTPAKPLTPSHLKGLLWTDVMFRATAPLADVTYRYSPTTYHLTEQTLGFWEFLDRTQKGLPYASLSEEEIGELYVRFRACAPPPADALRPYAHQVESNGWVHPASERVLRLWREHYAQLGLHDPGLTVHQPPGLGTEEMIERLVALGLGLDHRSSGGPVYLDATRHGLPLRQIVTADGRPNYLACALRELLPLAPAYDEVVLLYDTDLDADYRLLQRALTQLGPLVHRVPIGRVPIDGTIRSARHGGWHAYTAGALLKAVGTEADADVRRLGVRLYFVAVLGPGQAQSFRTDLLHRSLDRARQLLRRTTERGPGTSPLVDDLRRHRRDHTHVDPYRLTSSLLARARRTIDRDLLSTVYL	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	176.28	gnl|BL_ORD_ID|2147|hsp_num:0	2306		
